Showing results (331-340 of 502) with videos related to

Sort By:
Pageof 51
JACC. Cardiovascular Interventions|June 5, 2025
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment ElevationYuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
JACC. Cardiovascular Interventions|May 15, 2024
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary InterventionKo Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
Cardiovascular Intervention and Therapeutics|September 21, 2016
Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the CREDO-Kyoto registry cohort-2Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, et al.
Journal of the American Heart Association|September 17, 2021
Newly Diagnosed Atrial Fibrillation in Acute Myocardial InfarctionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation. Cardiovascular Interventions|May 14, 2025
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 TrialTetsuya Ishikawa, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
Circulation Reports|June 11, 2025
An Aspirin-Free Strategy for Patients Undergoing Staged Percutaneous Coronary Intervention - A Subgroup Analysis of the STOPDAPT-3 TrialKo Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 10, 2011
Chemical and biological characterization of four new linear cationic α-helical peptides from the venoms of two solitary eumenine waspsMarisa Rangel, Marcia Perez dos Santos Cabrera, Kohei Kazuma, et al.
BMJ Open|February 20, 2021
Prognostic value of reduction in left atrial size during a follow-up of heart failure: an observational studyMasayuki Shiba, Takao Kato, Takeshi Morimoto, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 24, 2024
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trialKo Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
Pageof 51